Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Medicina|June 28, 2023
Autoimmune encephalitis related to nivolumab followed by tumor regressionShirly J Mysler, Florencia Perazzo, Pablo Mandó
Lancet Regional Health. Americas|June 30, 2025
Main challenges to cancer care in Latin America: an analysis through breast cancer lensesGonzalo Gomez-Abuin, Pablo Mandó, Guiseppe Curigliano, et al.
Critical Reviews in Oncology/Hematology|March 6, 2021
Analysis of adverse events attribution and reporting in cancer clinical trials: A systematic reviewDiego Enrico, Federico Waisberg, Jeannette Burton, et al.
Ecancermedicalscience|April 29, 2021
Burnout syndrome in medical oncologists during the COVID-19 pandemic: Argentinian national surveyAndres Guercovich, Gonzalo Piazzioni, Federico Waisberg, et al.
Oncotargets and Therapy|February 27, 2023
HER2-Directed Therapy in Advanced Breast Cancer: Benefits and RisksPablo Mandó, Federico Waisberg, Rosario Pasquinelli, et al.
Breast (Edinburgh, Scotland)|August 28, 2021
Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy eraPablo Mandó, Sergio G Rivero, Manglio M Rizzo, et al.
JCO Global Oncology|April 11, 2025
Academic Collaborative Groups in Latin America: Key for High-Quality Standards and Personal and Collective GrowthPablo Mandó, Federico Waisberg, Gonzalo Gomez Abuin, et al.
Cancer Treatment and Research Communications|May 6, 2021
Appraising the quality of meta-analysis for breast cancer treatment in the adjuvant setting: A systematic reviewPablo Mandó, Ian Hirsch, Federico Waisberg, et al.
Critical Reviews in Oncology/Hematology|June 18, 2022
Assessing the methodological quality of quality-of-life analyses in first-line non-small cell lung cancer trials: A systematic reviewFederico Waisberg, Carlos Lopez, Diego Enrico, et al.
Cureus|February 20, 2026
Characteristics of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer Eligible for Adjuvant Cyclin-Dependent Kinase 4/6 (CDK4/6) Inhibitors: Real-Life Evidence in a Colombian Cancer CenterAlfredo Sebastian Golemba, Pablo Mandó, Adriana Lucia Jimenez Bolaño, et al.
Pageof 3